Adverse Consequences of Chronic Kidney Disease on Bone Health in Children

Area of Science:

• Nephrology
• Pediatrics
• Endocrinology
• Bone Metabolism

Background:

• Chronic kidney disease (CKD) mineral bone disorder (CKD-MBD) significantly affects skeletal integrity and growth in children.
• Early identification of mineral metabolism abnormalities is crucial in pediatric CKD.
• Common clinical manifestations include bone deformities, impaired linear growth, and increased fracture risk.

Purpose of the Study:

• To highlight the long-term skeletal consequences of CKD-MBD in pediatric populations.
• To emphasize the need for comprehensive assessment of bone health in children with CKD.
• To underscore the current gaps in evidence-based guidelines for managing pediatric CKD-MBD.

Main Methods:

• Review of existing literature on pediatric CKD-MBD.
• Discussion of emerging imaging techniques like high-resolution peripheral quantitative computed tomography (HR-pQCT) for bone assessment.
• Identification of limitations in current research, particularly the lack of large-scale studies correlating bone histology with serum biomarkers.

Main Results:

• Abnormalities in mineral metabolism markers are detectable early in pediatric CKD.
• HR-pQCT shows potential for comprehensive bone mineral density assessment and fracture prediction.
• A significant gap exists in large-scale studies linking bone histology and serum biomarkers.

Conclusions:

• The absence of robust evidence hinders the development of optimal management strategies for pediatric CKD-MBD.
• Further research integrating bone histology, advanced imaging, and serum biomarkers is essential.
• Establishing evidence-based guidelines is critical for improving skeletal health outcomes in children with CKD.